Beyond publishing academic articles, we create impact through sharing data, launching innovations, engaging with communities, and supporting industry with applied knowledge.

Data Sharing and Open Science

We make our structural data openly available to the scientific community through depositions in the Protein Data Bank, the Electron Microscopy Data Bank, and EMPIAR.

Academic Spin-offs

In 2023, I co-founded VirXcel, a biotechnology company dedicated to developing innovative strategies to prevent and mitigate respiratory viral infections by leveraging the unique properties of macrocyclic peptides.

Patents          

Title: Antiviral cyclic compounds (2023). Inventors: Vito Thijssen, Daniel L Hurdiss, Frank van Kuppeveld, Seino Jonkees      

Title: Sars-cov-2 (sars2, covid-19) antibodies (2021). Inventors: Franklin Gerardus Grosveld, Dubravka Drabek, Rien Van Haperen, Berend Jan Bosch, Juliette Fedry, Daniel L Hurdiss, Thijs Kuiken, Batholomeus Leonardus Haagmans, Barry Hubertus Gerardus Rockx

Industry White Papers

I Drulyte, S Koester, D Lundberg, K Eng, A Malyutin, A McGrath, C Wang, FJM van Kuppeveld, BJ Bosch, M Radjainia, J Thomas, M Magnay & DL Hurdiss. High-throughput cryo-EM epitope mapping of SARS-CoV-2 spike protein antibodies using EPU Multigrid. (February 2022)